Cover image supplied by Irene Chicote and Héctor G. Palmer, Stem Cells and Cancer Laboratory, Vall d’Hebrón Institute of Oncology—VHIO, Barcelona, Spain. Confocal microscopy image of immunofluorescence staining for β-catenin and FOXO3a proteins, as potential markers for prediction of drug response, in a histological section of a human colon carcinoma.

Cover image supplied by Irene Chicote and Héctor G. Palmer, Stem Cells and Cancer Laboratory, Vall d’Hebrón Institute of Oncology—VHIO, Barcelona, Spain. Confocal microscopy image of immunofluorescence staining for β-catenin and FOXO3a proteins, as potential markers for prediction of drug response, in a histological section of a human colon carcinoma.

Cover image supplied by Irene Chicote and Héctor G. Palmer, Stem Cells and Cancer Laboratory, Vall d’Hebrón Institute of Oncology—VHIO, Barcelona, Spain. Confocal microscopy image of immunofluorescence staining for β-catenin and FOXO3a proteins, as potential markers for prediction of drug response, in a histological section of a human colon carcinoma.

Cover image supplied by Irene Chicote and Héctor G. Palmer, Stem Cells and Cancer Laboratory, Vall d’Hebrón Institute of Oncology—VHIO, Barcelona, Spain. Confocal microscopy image of immunofluorescence staining for β-catenin and FOXO3a proteins, as potential markers for prediction of drug response, in a histological section of a human colon carcinoma.

Cover image supplied by Irene Chicote and Héctor G. Palmer, Stem Cells and Cancer Laboratory, Vall d’Hebrón Institute of Oncology—VHIO, Barcelona, Spain. Confocal microscopy image of immunofluorescence staining for β-catenin and FOXO3a proteins, as potential markers for prediction of drug response, in a histological section of a human colon carcinoma.